ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive cell therapy, ELIAS Cancer Immunotherapy (ECI®), has received full approval from the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback